JENNIFER HART: Open Payments
NPI 1356338982 · SPARTA, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,666 in 82 payments from 16 companies in 2025. Trend: 2023 $1,441 · 2024 $1,387 · 2025 $1,666
Food & beverage: $1,666
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $401 |
| Janssen Biotech, Inc. | 8 | $254 |
| Gilead Sciences, Inc. | 5 | $205 |
| Madrigal Pharmaceuticals | 9 | $156 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $112 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $86 |
| PFIZER INC. | 5 | $85 |
| QOL Medical, LLC | 4 | $74 |
| Ardelyx, Inc. | 4 | $66 |
| GENZYME CORPORATION | 3 | $64 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, Epclusa, DUPIXENT, ENTYVIO, XIFAXAN, Sucraid.
Industry payments across NJ — which companies pay providers there.
